Claudia M. Palena

Claudia M. Palena Claudia M. Palena is an American immunologist and cancer researcher working to advance cancer vaccines. She is a senior investigator and head of the immunoregulation section at the National Cancer Institute. Palena researches tumor immunology and cancer immunotherapy. IRP senior investigator Claudia Palena is now leading and over watching possible vaccines that might help the immune system fight off cancer. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Claudia Palena', query time: 0.01s Refine Results
  1. 1
    Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis

    Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis by Jeffrey Schlom, Claudia Palena, Kristen Fousek, Duane H Hamilton, Lucas A Horn, Haiyan Qin, Madeline Dahut, Shantel Angstadt

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines

    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines by Renee N Donahue, Jeffrey Schlom, James L Gulley, James W Hodge, Claudia Palena, Duane H Hamilton, Sofia R Gameiro

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

    Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific... by Renee N Donahue, Jeffrey Schlom, James L Gulley, Claudia Palena, Duane H Hamilton, Masafumi Iida, Maria del Mar Maldonado, Maria Gracia-Hernandez, Loc Huu Le

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

    Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity by Jeffrey Schlom, Claudia Palena, Kristen Fousek, Zhen Su, Duane H Hamilton, Hanne Lind, Lucas A Horn, Jeffrey Riskin, Heidi A Hempel, Kristen K McCampbell, Dean Y Maeda, John A Zebala

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models

    Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and n... by Lucas A. Horn, Hanne Lind, Kristen Fousek, Haiyan Qin, Nika Rajabian, Shantel Angstadt, Nicole Hsiao-Sanchez, Miriam M. Medina-Enriquez, Marcus D. Kelly, Clint T. Allen, Sarah M. Hammoudeh, Roberto Weigert, Dean Y. Maeda, John A. Zebala, Claudia Palena

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: